Sofinnova Investments related stories
All articles and analysis
peHUB Wire: Tuesday, September 15, 2009Competitive Landscape
- Week in deals, July 13, 2009
Summary of tech companies and other businesses that raised financing in the past week
- Intellikine Raises $51 Million
Intellikine Inc., a La Jolla, Calif.-based developer of small molecule drugs for cancer, inflammation and autoimmune diseases, has raised $51 million in Series B funding. Novartis Bioventures led the round, and was joined by U.S. Venture Partners, Biogen Idec and FinTech Global Capital. Return backers included Abingworth, CMEA Capital and Sofinnova Ventures. The round includes a $28.5 million initial calldown, with the remainder dependent on the achievement of certain milestones. Intellikine previously raised $12.5 million.
- peHUB Wire: Thursday, July 9, 2009
Random Ramblings
- peHUB Wire: Thursday, July 9, 2009
Random Ramblings
- Week in deals, July 6, 2009
Summary of tech companies and other businesses that raised financing in North America in the past week
- peHUB Wire: Monday, July 6, 2009
Monday Mouth-Off
- peHUB Wire: Monday, July 6, 2009
Monday Mouth-Off
- peHUB Wire: Wednesday, July 1, 2009
Q2 Data Dump